Physician profile

Thomas M Facelle

Urology · Golden, CO

NPI 1114227501

$7,127.02

in general payments reported to CMS, 2019-2025

52 companies · $1,683 in 2025

The $1,683 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$3,808.53

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Covidien LP $689.33 2019
Boston Scientific Corporation $650.22 2019-2025 Spaceoar Vue System - 10ml, Axonics, Rezum Generator
Janssen Biotech, INC. $514.53 2021-2025 Erleada, Carvykti, Rybrevant
Teleflex LLC $475.19 2021-2025 Urolift, Barrigel
Sumitomo Pharma America, INC. $456.83 2023-2025 Orgovyx, Gemtesa
Olympus America INC. $346.70 2019-2025 Itind System, Bovie
Astellas Pharma US INC $293.60 2019-2024 Xtandi, Myrbetriq
Neotract INC. $264.35 2019-2020
Abbvie INC. $236.83 2022-2025
Pfizer INC. $230.28 2019-2025
Tolmar, INC. $193.76 2023-2025 Jatenzo, Eligard
Procept Biorobotics Corporation $165.11 2023 Aquabeam Robotic System
Medtronic, INC. $158.36 2021-2022
Merck Sharp & Dohme LLC $155.19 2023-2025 Keytruda, Welireg, Lynparza
Dendreon Pharmaceuticals LLC $153.88 2020-2025 Provenge
Show all 52 companies
CompanyGeneral paymentsYearsTop products
Axonics, INC. $147.20 2021-2024 Bulkamid, Axonics
Bayer Healthcare Pharmaceuticals INC. $139.43 2024-2025
Antares Pharma, INC. $138.02 2019-2022
Myriad Genetic Laboratories, INC. $112.51 2021-2023 Prolaris
Urogen Pharma, INC. $107.03 2023-2025 Jelmyto
Endo Pharmaceuticals INC. $102.23 2023-2024 Xiaflex, Aveed, Edex
Novartis Pharmaceuticals Corporation $99.73 2025
Endo USA, INC. $98.52 2024-2025 Xiaflex, Aveed
Baxter Healthcare $88.93 2024 Perclot, Floseal
Tolmar Pharmaceuticals, INC. $88.84 2022
Rochester Medical Corporation $88.74 2020-2022
Myovant Sciences INC. $81.65 2021-2022
Progenics Pharmaceuticals, INC. $78.97 2023-2025 Pylarify
Sun Pharmaceutical Industries INC. $77.04 2023-2025 Yonsa
Telix Pharmaceuticals $68.80 2022-2024 Illuccix
Verity Pharmaceuticals INC. $68.40 2025 Tlando, Trelstar
Coloplast Corp $63.00 2021-2024
Blue Earth Diagnostics $56.40 2019-2025 Posluma
Hollister Incorporated $47.05 2022-2023 Vapro Plus Pocket
Astrazeneca Pharmaceuticals LP $43.04 2023 Lynparza
Laborie Medical Technologies Corp. $36.33 2024 Optilume Bph Drug Coated Balloon Catheter
Convatec INC. $33.84 2024
Abc Home Medical Supply, INC. $26.25 2022
180 Medical, INC. $22.53 2022
Innovation Technologies INC $21.15 2023 Irrisept
Steris Corporation $20.58 2024
Ambu INC. $20.54 2022
Amgen INC. $20.16 2019
Cook Medical LLC $19.48 2025 Litho 150
Photocure INC $19.07 2022
Caris Mpi, INC. $18.37 2025 Mi Cancer Seek
Kowa Pharmaceuticals America, INC. $17.49 2023 Seglentis
Dentsply Ih Ab $16.77 2025 Lofric
Ferring Pharmaceuticals INC. $16.44 2019
Dentsply Ih INC. $13.92 2019
Janssen Scientific Affairs, LLC $12.78 2020
Allergan, INC. $11.63 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Thomas M Facelle

$7,127.02

in general payments reported 2019-2025

Years
2019-2025
Top company
Covidien LP
Context
The $1,683 reported for 2025 was more than what 76% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/1328512/thomas-m-facelle

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.